UROMED CORP
SC 13D/A, 1996-08-16
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: FIBERCORE INC, S-1, 1996-08-16
Next: KELLSTROM INDUSTRIES INC, S-3, 1996-08-16





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                               (Amendment No. 2)*

 


                               UROMED CORPORATION
                           --------------------------
                                (Name of Issuer)

                           Common Stock, No Par Value
                             ----------------------
                         (Title of Class of Securities)

                                    917274102
                               ------------------
                                 (CUSIP Number)

                              Stephen M. Vine, Esq.
                    Akin, Gump, Strauss, Hauer & Feld, L.L.P.
                                 399 Park Avenue
                            New York, New York 10022
                                 (212) 872-1000
                   ------------------------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                 August 9, 1996
                            ------------------------
                      (Date of Event which Requires Filing
                               of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [_]

Check the following box if a fee is being paid with the statement [_]. (A fee is
not required only if the reporting person:  (1) has a previous statement on file
reporting  beneficial  ownership  of more  than  five  percent  of the  class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7)

Note: Six copies of this statement, including all exhibits, should be filed with
the  Commission.  See Rule 13d- 1(a) for other  parties to whom copies are to be
sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter disclosure
provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                         Continued on following page(s)
                                Page 1 of 7 Pages
 
<PAGE>

                                  SCHEDULE 13D

       CUSIP No.  917274102                                    Page 2 of 7 Pages


1       Name of Reporting Person
        S.S. or I.R.S. Identification No. of Above Person

               SOROS CAPITAL, L.P.

2       Check the Appropriate Box If a Member of a Group*
                                            a.  [_]
                                            b.  [x]

3       SEC Use Only

4       Source of Funds*

               Not Applicable

5       Check Box If Disclosure of Legal Proceedings Is Required Pursuant to 
        Items 2(d) or 2(e) [_]

6       Citizenship or Place of Organization

               BERMUDA

                      7      Sole Voting Power
 Number of                          1,445,454
   Shares
Beneficially          8      Shared Voting Power
  Owned By                          0
    Each
  Reporting           9      Sole Dispositive Power
   Person                           1,445,454
    With
                      10     Shared Dispositive Power
                                    0

11      Aggregate Amount Beneficially Owned by Each Reporting Person

                                    1,445,454

12      Check Box If the Aggregate Amount in Row (11) Excludes Certain
        Shares*              [_]

13      Percent of Class Represented By Amount in Row (11)

                                    5.47%

14      Type of Reporting Person*

               PN

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>

                                  SCHEDULE 13D

       CUSIP No.  917274102                                    Page 3 of 7 Pages


1       Name of Reporting Person
        S.S. or I.R.S. Identification No. of Above Person

               STEVEN J. GILBERT

2       Check the Appropriate Box If a Member of a Group*
                                            a.  [_]
                                            b.  [x]

3       SEC Use Only

4       Source of Funds*

               Not Applicable

5       Check Box If Disclosure of Legal Proceedings Is Required Pursuant to 
        Items 2(d) or 2(e) [_]

6       Citizenship or Place of Organization

               UNITED STATES

                      7      Sole Voting Power
 Number of                          1,660,297
   Shares
Beneficially          8      Shared Voting Power
  Owned By                          0
    Each
  Reporting           9      Sole Dispositive Power
   Person                           1,660,297
    With
                      10     Shared Dispositive Power
                                    0

11      Aggregate Amount Beneficially Owned by Each Reporting Person

                                    1,660,297

12      Check Box If the Aggregate Amount in Row (11) Excludes Certain
        Shares*              [_]

13      Pe cent of Class Represented By Amount in Row (11)

                                    6.28%

14      Type of Reporting Person*

               IA; IN

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>

                                                               Page 4 of 7 Pages


Item 1.   Security and Issuer.

          This  Amendment  No. 2 to  Schedule  13D  relates  to shares of Common
Stock, no par value (the "Shares"),  of UroMed Corporation (the "Issuer").  This
Amendment  No. 2 amends the initial  statement on  Schedule 13D  dated April 15,
1994 as  previously  amended by  Amendment  No. 1 thereto  dated  June 11,  1996
(together,  the "Initial  Statement") filed by the Reporting Persons (as defined
herein).  The address of the  principal  executive  offices of the Issuer is 64A
Street,  Needham,  Massachusetts  02194.  This Amendment No.2 is being filed to
report  the  recent  disposition  of Shares for the  accounts  of the  Reporting
Persons, as a result of which the percentage of the class of Shares of which the
Reporting Persons may be deemed the beneficial owners has decreased by more than
one percent. Capitalized terms used herein but not defined herein shall have the
meanings  given to them in the  Initial  Statement.  The  Initial  Statement  is
supplementally amended as set forth herein.

Item 5.   Interest in Securities of the Issuer.

          (a) The  aggregate  number  of Shares of which  Soros  Capital  may be
deemed  a  beneficial  owner  is the  1,445,454  Shares  held  for  its  account
(approximately 5.47% of the total number of Shares outstanding).

          The  aggregate  number of Shares of which Mr.  Gilbert may be deemed a
beneficial owner is 1,660,297 (approximately 6.28% of the total number of Shares
which would be  outstanding  assuming the  exercise of all of the stock  options
held for the  account of Mr.  Gilbert).  This number  consists of (i)  1,445,454
Shares held for the account of Soros  Capital,  (ii) 196,883 Shares held for the
account of Mr. Gilbert,  and (iii) 17,960 Shares issuable upon exercise of stock
options granted by the Issuer to Mr. Gilbert pursuant to the Issuer's 1991 Stock
Option Plan and a Stock Option Agreement dated October 8, 1993.

          The filing of this statement on a joint basis by Soros Capital and Mr.
Gilbert  shall not be construed as an  admission  that either is the  beneficial
owner of any Shares not held for their own accounts.

          (b) By virtue of his  position  as managing  general  partner of Soros
Capital,  Mr. Gilbert holds the sole power to direct the voting and  disposition
of Shares  held for the account of Soros  Capital.  Mr.  Gilbert  holds the sole
power to vote and dispose of Shares held for his account.

          (c) Except for the transactions listed in Annex B, which were effected
at the  direction  of  Mr.  Gilbert  and  were  executed  in  routine  brokerage
transactions  on the  over-the-counter  market,  there have been no transactions
effected  with  respect to the Shares  since June 17, 1996 (60 days prior to the
date hereof) for the accounts of either of the Reporting Persons.

          (d) The partners of Soros Capital have the right to participate in the
receipt of dividends  from,  or proceeds  from the sale of,  securities  held by
Soros Capital  (including the Shares) in accordance with their share partnership
interests in Soros Capital.

          (e) Not applicable.


<PAGE>

                                                               Page 5 of 7 Pages


Item 7.   Material to be Filed as Exhibits.

          (a) Joint Filing  Agreement as of June 11, 1996,  by and between Soros
Capital  and Mr.  Gilbert  (filed as  Exhibit  A to the  Initial  Statement  and
incorporated herein by reference).

          (b) Power of Attorney  dated June 7, 1996 granted by Steven J. Gilbert
in favor of Mr. Richard W. Gaenzle (filed as Exhibit B to the Initial  Statement
and incorporated herein by reference).

<PAGE>

                                                               Page 6 of 7 Pages
<TABLE>
<CAPTION>



                                                              ANNEX B
                                              RECENT TRANSACTIONS IN THE COMMON STOCK
                                                                OF
                                                        UROMED CORPORATION


 For the Account of      Date of Transaction      Nature of Transaction      Number of Shares           Price per Share
- -------------------     --------------------     ----------------------    -------------------        ------------------


<S>                           <C>                        <C>                     <C>                         <C>    
Soros Capital, L.P.            7/30/96                    Sale                     8,800                     $13.500
                               7/31/96                    Sale                    22,000                      12.750
                               8/01/96                    Sale                     8,800                      12.750
                               8/02/96                    Sale                    22,000                      12.800
                               8/05/96                    Sale                     4,400                      12.750
                               8/07/96                    Sale                    30,800                      12.562
                               8/08/96                    Sale                    26,400                      12.750
                               8/09/96                    Sale                    22,000                      12.813
                               8/12/96                    Sale                     8,800                      12.625
                               8/13/96                    Sale                    13,200                      12.563
                               8/14/96                    Sale                    30,800                      12.536
                               8/15/96                    Sale                     8,800                      12.500


Steven J. Gilbert              7/30/96                    Sale                     1,200                     $13.500
                               7/31/96                    Sale                     3,000                      12.750
                               8/01/96                    Sale                     1,200                      12.750
                               8/02/96                    Sale                     3,000                      12.800
                               8/05/96                    Sale                       600                      12.750
                               8/07/96                    Sale                     4,200                      12.562
                               8/08/96                    Sale                     3,600                      12.750
                               8/09/96                    Sale                     3,000                      12.813
                               8/12/96                    Sale                     1,200                      12.625
                               8/13/96                    Sale                     1,800                      12.563
                               8/14/96                    Sale                     4,200                      12.536
                               8/15/96                    Sale                     1,200                      12.500

</TABLE>

<PAGE>

                                                               Page 7 of 7 Pages

                                   SIGNATURES

          After  reasonable  inquiry and to the best of my knowledge and belief,
the  undersigned  certifies that the  information set forth in this statement is
true, complete and correct.

Date:  August 16, 1996

                                               SOROS CAPITAL, L.P.

                                               By: Steven J. Gilbert
                                                   Managing General Partner


                                               By: /s/ Richard W. Gaenzle
                                                   -------------------------
                                                   Richard W. Gaenzle
                                                   Attorney-in-Fact



Date:  August 16, 1996                         STEVEN J. GILBERT


                                               By: /s/ Richard W. Gaenzle
                                                   --------------------------
                                                   Richard W. Gaenzle
                                                   Attorney-in-Fact




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission